{"layout":"Indikator","sdg_goal":"3","goal_number":"3","indicator_number":"3.b.1","indicator_sort_order":"03-bb-01","permalink":"/3-b-1/","reporting_status":"complete","published":true,"data_non_statistical":false,"national_indicator_available":"<ul style='padding-left: 25px;'><li>DTP-Impfquote zum Schuleintritt</li> <li> Masern-Impfquote zum Schuleintritt</li> <li> Pneumokokken-Impfquote zum Schuleintritt</li> <li> HPV-Impfquote bei 15-j\u00e4hrigen M\u00e4dchen</li></ul>","comparison_sdg":"Die Zeitreihen entsprechen den globalen Metadaten.","goal_meta_national_link":"https://sdg-indikatoren.de/public/MetaDe/3.b.1.pdf","goal_meta_national_link_text":"Metadaten zu den dargestellten Zeitreihen","indicator_name":"Anteil der Zielbev\u00f6lkerung, der alle Impfungen laut nationalem Programm besitzt","target_name":"Forschung und Entwicklung zu Impfstoffen und Medikamenten f\u00fcr \u00fcbertragbare und nicht\u00fcbertragbare Krankheiten, von denen haupts\u00e4chlich Entwicklungsl\u00e4nder betroffen sind, unterst\u00fctzen, den Zugang zu bezahlbaren unentbehrlichen Arzneimitteln und Impfstoffen gew\u00e4hrleisten, im Einklang mit der Erkl\u00e4rung von Doha \u00fcber das TRIPS-\u00dcbereinkommen und die \u00f6ffentliche Gesundheit, die das Recht der Entwicklungsl\u00e4nder bekr\u00e4ftigt, die Bestimmungen in dem \u00dcbereinkommen \u00fcber handelsbezogene Aspekte der Rechte des geistigen Eigentums \u00fcber Flexibilit\u00e4ten zum Schutz der \u00f6ffentlichen Gesundheit voll auszusch\u00f6pfen, und insbesondere den Zugang zu Medikamenten f\u00fcr alle zu gew\u00e4hrleisten","target_id":"3.b","un_designated_tier":"<a href='https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/' title='Klicken Sie hier um weitere Informationen zur UN-Tier-Klassifikation zu erhalten.'  target='_blank'>Tier I</a>","un_custodian_agency":"Weltgesundheitsorganisation (WHO)<br>Kinderhilfswerk der Vereinten Nationen (UNICEF)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"Metadaten zu diesem Indikator","source_active_1":true,"source_organisation_1":"Robert Koch-Institut (RKI)","source_organisation_logo_1":"<a href=\"https://www.rki.de/DE/Home/homepage_node.html\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgDe/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\"/></a>","source_url_1":"https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2020/Ausgaben/32-33_20.pdf","source_url_text_1":"Epidemiologisches Bulletin  32+33/2020","source_active_2":true,"source_organisation_2":"Informationssystem der Gesundheitsberichterstattung des Bundes (GBE)","source_organisation_logo_2":"<a href=\"http://www.gbe-bund.de/gbe10/pkg_isgbe5.prc_isgbe?p_uid=gast&p_aid=50815950&p_sprache=D\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgDe/gbe.png\" alt=\"Logo gbe\" style=\"height:60px; width:148px\"/></a>","source_url_2":"http://www.gbe-bund.de/gbe10/I?I=831:27110398","source_url_text_2":"Impfquote der Kinder mit vorgelegtem Impfausweis bei Einschulungsuntersuchungen","source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"data_keywords":"Indikator 3.b.1, TP-Impfquote zum Schuleintritt, HPV-Impfquote bei 15-j\u00e4hrigen M\u00e4dchen, Masern-Impfquote zum Schuleintritt, Pneumokokken-Impfquote zum Schuleintritt, Weltgesundheitsorganisation (WHO), Kinderhilfswerk der Vereinten Nationen (UNICEF), Rober","data_show_map":false,"data_start_values":null,"computation_units":"Prozent","copyright":"&copy; Statistisches Bundesamt (Destatis), 2021","data_footnote":"DTP: Diphtherie, Tetanus, Pertussis (Keuchhusten), HPV: Humane Papillomviren. 08/2014: Herabsetzung des empfohlenen Impfalters f\u00fcr die Impfung gegen HPV von ehemals 12-17 Jahren mit einem 3-Dosen-Impfschema auf 9-14 Jahre mit einem 2-Dosen-Impfschema. Nachholimpfung (mit 3 Impfstoffdosen) bis 17 Jahre m\u00f6glich. 09/2015: Reduzierung des Impfschemas der Standardimpfung gegen Pneumokokken f\u00fcr reifgeborene S\u00e4uglinge von 4 (3+1-Schema) auf 3 Impfstoffdosen (2+1-Schema). 06/2018: Einf\u00fchrung der HPV-Impfung zus\u00e4tzlich f\u00fcr Jungen.","graph_title":"Anteil der Zielbev\u00f6lkerung, der alle Impfungen laut nationalem Programm besitzt","graph_type":"line","show_line":true,"span_gaps":true,"precision":[{"decimals":1}],"previous":"3-a-1","next":"3-b-2","national_geographical_coverage":"Deutschland","national_data_update_url_text":"2021-06-02: see changes on GitHub","national_data_update_url":"https://github.com/G205SDGs/sdg-data/commit/e81a0d7ec62e464d40557e41d4e50b909c215c95","national_metadata_update_url_text":"2021-07-02: see changes on GitHub","national_metadata_update_url":"https://github.com/G205SDGs/sdg-data/commit/6a415365b7356cffd44a7d0bbd9465e20ed45390","page_content":"\n<span></span>","en":{"language":"en","national_indicator_available":"<ul style='padding-left: 25px;'><li>DTP vaccination coverage at school entry</li> <li> Measles vaccination coverage at school entry</li> <li> Pneumococcal vaccination coverage at school entry</li> <li> HPV vaccination coverage among 15 year-old girls</li></ul>","comparison_sdg":"The time series are compliant with the global metadata.","goal_meta_national_link_text":"Metadata on the presented time series","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","target_name":"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","un_designated_tier":"<a href=\"https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/\" title=\"Click here for more information on the UN tier classification.\"  target=\"_blank\">Tier I</a>","un_custodian_agency":"World Health Organization (WHO)<br>United Nations International Children's Fund (UNICEF)","goal_meta_link_text":"Metadata on this indicator","goal_meta_2_link_text":null,"goal_meta_3_link_text":null,"source_organisation_1":"Robert Koch Institute","source_organisation_logo_1":"<a href=\"https://www.rki.de/EN/Home/homepage_node.html\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgEn/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\" /></a>","source_url_text_1":"Epidemiological Bulletin 32+33/2020 (only available in German)","source_organisation_2":"Information System of the Federal Health Monitoring","source_organisation_logo_2":"<a href=\"https://www.gbe-bund.de/gbe10/pkg_isgbe5.prc_isgbe?p_uid=gast&p_aid=50815950&p_sprache=E\"><img src=\"https://g205sdgs.github.io/sdg-indicators/public/OrgImgEn/gbe.png\" alt=\"Logo gbe\" style=\"height:60px; width:148px\" /></a>","source_url_2":"http://www.gbe-bund.de/gbe10/I?I=831:27110398E","source_url_text_2":"Vaccination coverage of children presenting their vaccination card at school entry health examinations","computation_units":"Percentage","copyright":"&copy; Federal Statistical Office (Destatis), 2021","data_footnote":"DTP: Diphtheria, tetanus, pertussis, HPV: Humane papillomavirus. 08/2014: Reduction of the recommended vaccination age for HPV vaccination from formerly 12-17 years with a 3-dose vaccination schedule to 9-14 years with a 2-dose vaccination schedule. Repeat vaccination (with 3 doses of vaccine) possible up to 17 years. 09/2015: Reduction of the vaccination schedule of the standard pneumococcal vaccine for mature-born infants from 4 (3+1 schedule) to 3 doses of vaccine (2+1 schedule). 06/2018: Introduction of HPV vaccination additionally for boys.","graph_title":"Proportion of the target population covered by all vaccines included in their national programme","national_geographical_coverage":"Germany","page_content":"\n<span></span>"},"indicator":"3.b.1"}